Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06695767 · ClinicalTrials.gov registry record · NA
Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder
A NA study of Major Depressive Disorder and Epilepsy, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 2
- Study locations
NCT06695767: Recruiting NA study of Major Depressive Disorder and Epilepsy, sponsored by The University of Texas Health Science Center, Houston.
NCT06695767 is a NA study of Major Depressive Disorder and Epilepsy that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 16 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06695767, a NA study of Major Depressive Disorder and Epilepsy, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to examine the feasibility and acceptability of an online group Neuro-behavioral Therapy (NBT) with text messaging intervention for Veterans with epilepsy and major depressive disorder (MDD).
Primary Outcome
This is defined as the number enrolled divided by the number of eligible participants screened
Conditions Studied
Interventions
- BEHAVIORAL Neurobehavioral therapy
Study Locations (2)
Texas
- Michael E. DeBakey VA Medical Center - Houston
- The University of Texas health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2024-12-19 |
| Est. Completion | 2025-04-01 |
| Phase | NA |
What NCT06695767 shows while recruiting
NCT06695767 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Neurobehavioral therapy is the first listed.
NCT06695767 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06695767 about?
NCT06695767 is a clinical study titled "Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder". The purpose of this study is to examine the feasibility and acceptability of an online group Neuro-behavioral Therapy (NBT) with text messaging intervention for Veterans with epilepsy and major depressive disorder (MDD).
What is the current status of trial NCT06695767?
This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2024-12-19. Estimated completion is 2025-04-01.
What conditions does trial NCT06695767 study?
This clinical trial studies the following conditions: Major Depressive Disorder, Epilepsy.
What interventions are being tested in trial NCT06695767?
The interventions under investigation include: Neurobehavioral therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06695767?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06695767 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06695767's enrollment target sits among peer trials
16 257th of 282 higher than 23 of 282 other Major Depressive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Major Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
RECRUITING · NA
-
Neural Correlates of Stress and Perceived Control in Adolescent Depression
RECRUITING · NA
-
Positive Processes and Transition to Health (PATH)
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Amygdala Neurofeedback for Depression - Large Scale Clinical Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI